首页> Multiple sclerosis and related disorders> Disease modifying treatment guidelines for multiple sclerosis in the United Arab Emirates.

Disease modifying treatment guidelines for multiple sclerosis in the United Arab Emirates.

导出 LinkOut

翻译打印收藏纠错

第一作者： Anu,Jacob

第一单位： Neurological Institute, Cleveland Clinic, Abu Dhabi, United Arab Emirates; The Walton Centre, Liverpool, United Kingdom. Electronic address: jacoba@clevelandclinicabudhabi.ae.

作者： Anu,Jacob ^[1] ; Ahmed Osman,Shatila ^[2] ; Jihad,Inshasi ^[3] ; Joelle,Massouh ^[4] ; Ruquia,Mir ^[5] ; Suzan,Noori ^[6] ; Bassem,Yamout ^[7] ; UAE National Multiple Sclerosis Society

作者单位： Neurological Institute, Cleveland Clinic, Abu Dhabi, United Arab Emirates; The Walton Centre, Liverpool, United Kingdom. Electronic address: jacoba@clevelandclinicabudhabi.ae. ^[1] Department of Neurology, Sheikh Shakhbout Medical City Abu Dhabi, United Arab Emirates. ^[2] Department of Neurology, Rashid Hospital and Dubai Medical College, Dubai Health Authority, Dubai, United Arab Emirates. ^[3] Neurology Institute and Multiple Sclerosis Centre, Harley Street Medical centre, Abu Dhabi, United Arab Emirates. ^[4] Abu Dhabi stem Cell Clinic, United Arab Emirates. ^[5] University Hospital Sharjah, United Arab Emirates. ^[6] Neurology Institute and Multiple Sclerosis Centre, Harley Street Medical centre, Abu Dhabi, United Arab Emirates; American University of Beirut, Lebanon. ^[7]

关键词 Disease modifying treatment Gulf Middle East Multiple Sclerosis National guideline UAE United Arab Emirates

医学主题词人类(Humans);免疫因子类(Immunologic Factors);多发性硬化(Multiple Sclerosis);阿拉伯联合酋长国(United Arab Emirates)

DOI 10.1016/j.msard.2024.105703

PMID 38924933

发布时间 2026-01-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交